MPG.eBooks - Search Results - "finality"

Search alternatives:
"finality" » "finally", "finalize"

Cover Image

1

CADTH Canadian Drug Expert Committee recommendation (final): Letermovir (Prevymis -- Merck Canada Inc.) indication : cytomegalovirus infection, prophylaxis

Published 2018

CADTH

Cover Image

2

CADTH Canadian Drug Expert Committee recommendation (final): Letermovir (Prevymis -- Merck Canada Inc.) indication : cytomegalovirus infection, prophylaxis

Published 2018

CADTH

Cover Image

3

Clinical review report: Etonogestrel extended-release subdermal implant (Nexplanon) : Merck Canada Inc. : indication: for the prevention of pregnancy

Published 2020

Canadian Agency for Drugs and Technologies in Health

Cover Image

4

Clinical review report: Letermovir (Prevymis) (Merck Canada Inc.)

Published 2018

Canadian Agency for Drugs and Technologies in Health

Cover Image

5

CADTH Canadian Drug Expert Committee recommendation: Etonogestrel extended-release subdermal implant (Nexplanon -- Merck Canada Inc.) : indication : prevention of pregnancy for up...

Published 2020

Canadian Agency for Drugs and Technologies in Health

Cover Image

6

Clinical review report: Letermovir (Prevymis) (Merck Canada Inc.)

Published 2018

Canadian Agency for Drugs and Technologies in Health

Cover Image

7

Pharmacoeconomic review report: Letermovir (Prevymis) (Merck Canada Inc.)

Published 2018

CADTH

Cover Image

8

Pharmacoeconomic review report: Letermovir (Prevymis) (Merck Canada Inc.)

Published 2018

CADTH

Cover Image

9

Pharmacoeconomic report: Etonogestrel extended-release subdermal implant (Nexplanon) : Merck Canada Inc. : indication: for the prevention of pregnancy

Published 2020

Canadian Agency for Drugs and Technologies in Health